全文获取类型
收费全文 | 203篇 |
免费 | 15篇 |
国内免费 | 6篇 |
出版年
2023年 | 4篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 8篇 |
2019年 | 10篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 4篇 |
2015年 | 6篇 |
2014年 | 6篇 |
2013年 | 2篇 |
2012年 | 5篇 |
2011年 | 5篇 |
2010年 | 4篇 |
2009年 | 4篇 |
2008年 | 6篇 |
2007年 | 2篇 |
2006年 | 5篇 |
2005年 | 4篇 |
2004年 | 9篇 |
2003年 | 9篇 |
2002年 | 8篇 |
2001年 | 6篇 |
2000年 | 9篇 |
1999年 | 13篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1992年 | 7篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1975年 | 7篇 |
1974年 | 2篇 |
1973年 | 6篇 |
1972年 | 4篇 |
1971年 | 2篇 |
排序方式: 共有224条查询结果,搜索用时 31 毫秒
11.
Methods for the analysis of unmatched case-control data based on a finite population sampling model are developed. Under this model, and the prospective logistic model for disease probabilities, a likelihood for case-control data that accommodates very general sampling of controls is derived. This likelihood has the form of a weighted conditional logistic likelihood. The flexibility of the methods is illustrated by providing a number of control sampling designs and a general scheme for their analyses. These include frequency matching, counter-matching, case-base, randomized recruitment, and quota sampling. A study of risk factors for childhood asthma illustrates an application of the counter-matching design. Some asymptotic efficiency results are presented and computational methods discussed. Further, it is shown that a 'marginal' likelihood provides a link to unconditional logistic methods. The methods are examined in a simulation study that compares frequency and counter-matching using conditional and unconditional logistic analyses and indicate that the conditional logistic likelihood has superior efficiency. Extensions that accommodate sampling of cases and multistage designs are presented. Finally, we compare the analysis methods presented here to other approaches, compare counter-matching and two-stage designs, and suggest areas for further research.To whom correspondence should be addressed. 相似文献
12.
We propose an algorithm for constructing minimax D-optimal designs for the logistic model when only the ranges of the values for both parameters are assumed known. Properties of these designs are studied and compared with optimal Bayesian designs and Sitter's (1992, Biometrics, 48, 1145-1155) minimax D-optimal kk-designs. Examples of minimax D-optimal designs are presented for the logistic and power logistic models, including a dose-response design for rheumatoid arthritis patients. 相似文献
13.
We consider a response adaptive design of clinical trials with a variance‐penalized criterion. It is shown that this criterion evaluates the performance of a response adaptive design based on both the number of patients assigned to the better treatment and the power of the statistical test. A new proportion of treatment allocation is proposed and the doubly biased coin procedure is used to target the proposed proportion. Under reasonable assumptions, the proposed design is demonstrated to generate an asymptotic variance of allocation proportions, which is smaller than that of the drop‐the‐loser design. Simulation comparisons of the proposed design with some existing designs are presented. 相似文献
14.
15.
Matthew J. Gurka Christopher S. Coffey Kelly K. Gurka 《Biometrical journal. Biometrische Zeitschrift》2010,52(5):590-603
Study planning often involves selecting an appropriate sample size. Power calculations require specifying an effect size and estimating “nuisance” parameters, e.g. the overall incidence of the outcome. For observational studies, an additional source of randomness must be estimated: the rate of the exposure. A poor estimate of any of these parameters will produce an erroneous sample size. Internal pilot (IP) designs reduce the risk of this error ‐ leading to better resource utilization ‐ by using revised estimates of the nuisance parameters at an interim stage to adjust the final sample size. In the clinical trials setting, where allocation to treatment groups is pre‐determined, IP designs have been shown to achieve the targeted power without introducing substantial inflation of the type I error rate. It has not been demonstrated whether the same general conclusions hold in observational studies, where exposure‐group membership cannot be controlled by the investigator. We extend the IP to observational settings. We demonstrate through simulations that implementing an IP, in which prevalence of the exposure can be re‐estimated at an interim stage, helps ensure optimal power for observational research with little inflation of the type I error associated with the final data analysis. 相似文献
16.
目的 探讨全程无缝隙护理模式对肿瘤科护理工作质量的影响。方法 2013年1月-12月我院肿瘤科采用无缝隙护理模式的患者120例为观察组,2012年1月-12月采用常规护理的120例肿瘤科患者为对照组,对比两组患者的心理舒适度、患者对护理工作的满意度。结果 观察组患者的安全感、满足感、尊重感所占比例均高于对照组,差异均有统计学意义(P<0.05)。观察组患者对护士的工作能力、关爱与沟通、服务热情主动、病区管理、健康教育满意度均高于对照组,差异均有统计学意义(P<0.05)。结论 全程无缝隙护理模式应用于肿瘤科护理,能够有效改善患者不良情绪,提高护理工作质量及患者满意度。 相似文献
17.
18.
Joshua M. Tebbs William H. Swallow 《Biometrical journal. Biometrische Zeitschrift》2003,45(5):618-630
Binomial group testing involves pooling individuals into groups and observing a binary response on each group. Results from the group tests can then be used to draw inference about population proportions. Its use as an experimental design has received much attention in recent years, especially in public‐health screening experiments and vector‐transfer designs in plant pathology. We investigate the benefits of group testing in situations wherein one desires to test whether or not probabilities are increasingly ordered across the levels of an observed qualitative covariate, i.e., across strata of a population or among treatment levels. We use a known likelihood ratio test for individual testing, but extend its use to group‐testing situations to show the increases in power conferred by using group testing when operating in this constrained parameter space. We apply our methods to data from an HIV study involving male subjects classified as intraveneous drug users. 相似文献
19.
The main purpose of a phase IIA trial of a new anticancer therapy is to determine whether the therapy has sufficient promise against a specific type of tumor to warrant its further development. The therapy will be rejected for further investigation if the true response rate is less than some uninteresting level and the test of hypothesis is powered at a specific target response rate. Two-stage designs are commonly used for this situation. However, in many situations investigators often express concern about uncertainty in targeting the alternative hypothesis to study power at the planning stage. In this article, motivated by a real example, we propose a strategy for adaptive two-stage designs that will use the information at the first stage of the study to either reject the therapy or continue testing with either an optimistic or a skeptic target response rate, while the type I error rate is controlled. We also introduce new optimal criteria to reduce the expected total sample size. 相似文献
20.
We propose a general method of designing an experiment when there are potentially failing trials. We use polynomial models and the Michaelis-Menten model as examples and construct different types of optimal designs under a broad class of response probability functions. We show that the usual optimal designs, that assume all observations are available at the end of the experiment, can be quite inefficient if the anticipated missingness pattern is not accounted for at the design stage. We also investigate robustness properties of the proposed designs to specification of their nominal values and the response probability functions. 相似文献